Literature DB >> 26137214

The role of adipokines in gestational diabetes mellitus.

Marwa R Al-Badri1, Mira S Zantout1, Sami T Azar2.   

Abstract

Gestational diabetes mellitus (GDM) is a complication of pregnancy that is characterized by impaired glucose tolerance with onset or first recognition during pregnancy. The reported prevalence of GDM varies between 0.6% and 20% of pregnancies depending on screening method, gestational age and the population studied. GDM is characterized by pancreatic β-cell function that is insufficient to meet the body's insulin needs. Available evidence suggests that β-cell defects in GDM result from the same spectrum of causes that underline hyperglycemia in general, including autoimmune disease, monogenic causes and insulin resistance. Adipokines are proteins secreted from the adipocytes and are believed to have a metabolic influence. Our review suggests that, in GDM, various adipokines, mainly leptin and adiponectin, are dysregulated. These two adipokines might have both prognostic and pathophysiological significance in this disease.

Entities:  

Keywords:  adipokines; adiponectin; gestational diabetes; insulin resistance; leptin; β cell

Year:  2015        PMID: 26137214      PMCID: PMC4480551          DOI: 10.1177/2042018815577039

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  21 in total

Review 1.  Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia.

Authors:  Konstanze Miehle; Holger Stepan; Mathias Fasshauer
Journal:  Clin Endocrinol (Oxf)       Date:  2012-01       Impact factor: 3.478

2.  Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies.

Authors:  Martha Lappas; Kirin Yee; Michael Permezel; Gregory E Rice
Journal:  J Endocrinol       Date:  2005-09       Impact factor: 4.286

3.  Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.

Authors:  R Retnakaran; A J G Hanley; N Raif; C R Hirning; P W Connelly; M Sermer; S E Kahn; B Zinman
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

4.  Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes.

Authors:  M Kinalski; B Telejko; M Kuźmicki; A Kretowski; I Kinalska
Journal:  Horm Metab Res       Date:  2005-07       Impact factor: 2.936

5.  Failure to increase insulin secretory capacity during pregnancy-induced insulin resistance is associated with ethnicity and gestational diabetes.

Authors:  Kjersti Mørkrid; Anne K Jenum; Line Sletner; Mari H Vårdal; Christin W Waage; Britt Nakstad; Siri Vangen; Kåre I Birkeland
Journal:  Eur J Endocrinol       Date:  2012-08-13       Impact factor: 6.664

6.  Glucagon stimulation test: assessment of beta-cell function in gestational diabetes mellitus.

Authors:  M L Jacobs; S Verhoog; W H van der Linden; W M Huisman; H C Wallenburg; R F Weber
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1994-07       Impact factor: 2.435

7.  Adiponectin/leptin ratio and insulin resistance in pregnancy.

Authors:  A Skvarca; M Tomazic; R Blagus; B Krhin; A Janez
Journal:  J Int Med Res       Date:  2013-01-23       Impact factor: 1.671

8.  Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia.

Authors:  Holger Stepan; Susan Kralisch; Katrin Klostermann; Susanne Schrey; Constanze Reisenbüchler; Michael Verlohren; Hans-Joachim Verlohren; Kathrin Drynda; Matthias Blüher; Michael Stumvoll; Jürgen Kratzsch; Peter Kovacs; Mathias Fasshauer
Journal:  Metabolism       Date:  2009-12-31       Impact factor: 8.694

9.  Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.

Authors:  Ravi Retnakaran; Sandy Shen; Anthony J Hanley; Vladimir Vuksan; Jill K Hamilton; Bernard Zinman
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

10.  Changes in placental adipocytokine gene expression associated with gestational diabetes mellitus.

Authors:  M Meller; C Qiu; S Vadachkoria; D F Abetew; D A Luthy; M A Williams
Journal:  Physiol Res       Date:  2005-12-12       Impact factor: 1.881

View more
  17 in total

1.  Predictive value of fetal hepatic biometry for birth weight and cord blood markers in gestational diabetes.

Authors:  J Garcia-Flores; M Cruceyra; M Cañamares; A Garicano; O Nieto; I Tamarit
Journal:  J Perinatol       Date:  2016-05-12       Impact factor: 2.521

2.  Associations between adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and biomarkers of inflammation, hormonal, and insulin response.

Authors:  Fred K Tabung; Teresa T Fung; Jorge E Chavarro; Stephanie A Smith-Warner; Walter C Willett; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-11-14       Impact factor: 7.396

Review 3.  Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Errol R Norwitz; Pål Aukrust; Thor Ueland
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

Review 4.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

Review 5.  Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls.

Authors:  Emilio Herrera; Henar Ortega-Senovilla
Journal:  Curr Diab Rep       Date:  2018-02-05       Impact factor: 4.810

Review 6.  Variation of Leptin During Menstrual Cycle and Its Relation to the Hypothalamic-Pituitary-Gonadal (HPG) Axis: A Systematic Review.

Authors:  Ayad Mohammed Salem
Journal:  Int J Womens Health       Date:  2021-05-10

Review 7.  Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives.

Authors:  Carmela Santangelo; Alessandra Zicari; Elisabetta Mandosi; Beatrice Scazzocchio; Emanuela Mari; Susanna Morano; Roberta Masella
Journal:  Br J Nutr       Date:  2016-02-16       Impact factor: 3.718

8.  Serum adiponectin levels in gestational diabetes mellitus.

Authors:  Abhijit Bhograj; K M Suryanarayana; Ashwini Nayak; N S Murthy; Mala Dharmalingam; Pramila Kalra
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

Review 9.  Association Between Neutrophil-Lymphocyte Ratio and Gestational Diabetes-A Systematic Review and Meta-Analysis.

Authors:  Nikolai Paul Pace; Josanne Vassallo
Journal:  J Endocr Soc       Date:  2021-03-23

10.  The Potential Role of Chemerin, Lipocalin 2, and Apelin in the Diagnosis and Pathophysiology of Gestational Diabetes Mellitus.

Authors:  Radzisław Mierzyński; Elżbieta Poniedziałek-Czajkowska; Dominik Dłuski; Maciej Kamiński; Agnieszka Mierzyńska; Bożena Leszczyńska-Gorzelak
Journal:  J Diabetes Res       Date:  2021-06-09       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.